Most Popular Articles

February 2023

1. Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study
2. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
3. Association of COVID-19 with New-Onset Alzheimer’s Disease
4. A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
5. Aluminum and Amyloid-β in Familial Alzheimer’s Disease
6. Is Caffeine a Cognitive Enhancer?
7. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
8. Caffeine, Mental Health, and Psychiatric Disorders
9. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
10. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial

January 2023

1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
2. Association of COVID-19 with New-Onset Alzheimer’s Disease
3. Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study
4. Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden
5. Exposure to World Trade Center Dust Exacerbates Cognitive Impairment and Evokes a Central and Peripheral Pro-Inflammatory Transcriptional Profile in an Animal Model of Alzheimer’s Disease
6. Is Caffeine a Cognitive Enhancer?
7. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
8. Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer’s Disease: A Randomized Clinical Trial
9. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
10. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial

December 2022

1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
2. Association of COVID-19 with New-Onset Alzheimer’s Disease
3. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
4. Is Caffeine a Cognitive Enhancer?
5. Is the Frontal Lobe the Primary Target of SARS-CoV-2?
6. Caffeine and Adenosine
7. Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden
8. It’s Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer’s Disease Research?
9. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
10. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures

November 2022

1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
2. Association of COVID-19 with New-Onset Alzheimer’s Disease
3. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
4. Is Caffeine a Cognitive Enhancer?
5. Caffeine, Mental Health, and Psychiatric Disorders
6. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
7. Caffeine and Adenosine
8. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
9. COVID-19 as a Risk Factor for Alzheimer’s Disease
10. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands

October 2022

1. Association of COVID-19 with New-Onset Alzheimer’s Disease
2. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
3. High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations
4. Is Caffeine a Cognitive Enhancer?
5. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
6. Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment
7. Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers
8. Caffeine, Mental Health, and Psychiatric Disorders
9. Caffeine and Adenosine
10. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

September 2022

1. Association of COVID-19 with New-Onset Alzheimer’s Disease
2. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
3. Is Caffeine a Cognitive Enhancer?
4. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
5. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
6. Caffeine, Mental Health, and Psychiatric Disorders
7. Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
8. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
9. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
10. Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment

August 2022

1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
2. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
3. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
4. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
5. Is Caffeine a Cognitive Enhancer?
6. Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1
7. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
8. The Dark Side of Alzheimer’s Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level
9. Air Pollution and Dementia: A Systematic Review
10. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

July 2022

1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
2. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
3. Automated Early Detection of Alzheimer’s Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks
4. Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging
5. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
6. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
7. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
8. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
9. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions
10. Air Pollution and Dementia: A Systematic Review

June 2022

1. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
2. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
3. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
4. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
5. Is Caffeine a Cognitive Enhancer?
6. Caffeine and Adenosine
7. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
8. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
9. A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging
10. Caffeine, Mental Health, and Psychiatric Disorders

May 2022

1. Is Caffeine a Cognitive Enhancer?
2. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
3. Caffeine, Mental Health, and Psychiatric Disorders
4. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
5. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
6. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
7. Caffeine and Adenosine
8. Neurobiology of COVID-19
9. Impact of Social Isolation on People with Dementia and Their Family Caregivers
10. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis

April 2022

1. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
2. Is Caffeine a Cognitive Enhancer?
3. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
4. Caffeine and Adenosine
5. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
6. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
7. Making the Case for Accelerated Withdrawal of Aducanumab
8. Caffeine, Mental Health, and Psychiatric Disorders
9. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
10. Neurobiology of COVID-19

March 2022

1. Is Caffeine a Cognitive Enhancer?
2. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
3. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
4. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
5. Caffeine and Adenosine
6. Caffeine, Mental Health, and Psychiatric Disorders
7. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
8. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
9. Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early AD
10. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial